About
Wiseneuro is a spin-off from the Italian Institute of Technology in Genoa developing drugs for neurological diseases, including treatments targeting symptoms linked to Down syndrome, autism spectrum disorders, epilepsy, and rare neurodevelopmental diseases, with positive preclinical evidence and ongoing drug development.
Explore Wiseneuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.